AbCellera Biologics Inc. (ABCL)

CIK 1703057 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AbCellera Biologics Inc..

Recent SEC filings

FiledFormAccession number
Aug 24, 202640001628280-26-058684
Aug 18, 202640001834423-26-000008
Aug 14, 202640001834411-26-000008
Aug 14, 202640001628280-26-057007
Aug 13, 2026424B50001193125-26-349333
Aug 13, 20268-K0001193125-26-349353
Aug 13, 202640001628280-26-056653
Aug 11, 2026424B50001193125-26-344944
Aug 10, 20268-K0001703057-26-000053
Aug 7, 20268-K0001703057-26-000049
Aug 5, 20268-K0001703057-26-000044
Aug 5, 202610-Q0001703057-26-000046
Jul 29, 20268-K0001703057-26-000039
Jul 6, 202630001628280-26-047399
Jul 6, 20268-K0001703057-26-000037
Jul 6, 202640001628280-26-047396
Jul 6, 202640001628280-26-047400
Jun 17, 20268-K0001703057-26-000035
Jun 12, 202640001628280-26-042739
Jun 12, 202640001685889-26-000002
Jun 12, 20268-K0001703057-26-000033
Jun 12, 202640001834423-26-000006
Jun 11, 202630001628280-26-042450
Jun 5, 20268-K0001703057-26-000031
Jun 3, 202640001834411-26-000006